Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2016 · Clinical Cancer Research · 454 citations
https://doi.org/10.1158/1078-0432.ccr-15-1535
E
Eileen Kim
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
2.0K
Citations
16
h-index
16
i10-index
Eileen Kim is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Glioma Diagnosis and Treatment & CAR-T cell therapy research. The author has an h-index of 16, co-authored 34 publications.
ORCID: 0000-0002-5469-4058Papers by this author
worksSoluble PD-L1 reprograms blood monocytes to prevent cerebral edema and facilitate recovery after ischemic stroke
2023 · Brain Behavior and Immunity · 31 citations
https://doi.org/10.1016/j.bbi.2023.12.007
159 PD-1 Agonism as a Strategy to Prevent Neuroinflammation After Acute Large Vessel Occlusion
2024 · Neurosurgery · 0 citations
https://doi.org/10.1227/neu.0000000000002809_159
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat